🔴 Telix Pharmaceuticals is trading 6.09% down today with no clear company-specific catalyst identified

Telix Pharmaceuticals is trading at A$15.74, -6.09%, with no clear company-specific announcement identified for September 11, 2026.

• Recent updates include BiPASS enrollment completion and the upcoming Pixclara FDA decision.
• The September 11 PDUFA date remains a key event; no approval or rejection was confirmed.
• Broader market indices were broadly flat, so macro sentiment does not clearly explain the decline.